During the last session, X4 Pharmaceuticals Inc (NASDAQ:XFOR)’s traded shares were 2.25 million, with the beta value of the company hitting 0.47. At the end of the trading day, the stock’s price was $1.29, reflecting an intraday gain of 4.88% or $0.06. The 52-week high for the XFOR share is $2.58, that puts it down -100.0 from that peak though still a striking 55.81% gain since the share price plummeted to a 52-week low of $0.57. The company’s market capitalization is $216.64M, and the average trade volume was 2.44 million shares over the past three months.
X4 Pharmaceuticals Inc (NASDAQ:XFOR) trade information
X4 Pharmaceuticals Inc (XFOR) registered a 4.88% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.88% in intraday trading to $1.29, hitting a weekly high. The stock’s 5-day price performance is 7.95%, and it has moved by -11.64% in 30 days. Based on these gigs, the overall price performance for the year is -9.79%.
X4 Pharmaceuticals Inc (XFOR) estimates and forecasts
Statistics show that X4 Pharmaceuticals Inc has outperformed its competitors in share price, compared to the industry in which it operates. X4 Pharmaceuticals Inc (XFOR) shares have gone up 56.95% during the last six months, with a year-to-date growth rate more than the industry average at 17.54% against 12.90.
Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 510k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 73.95%. While earnings are projected to return 20.80% in 2024.
XFOR Dividends
X4 Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
